Univest
Univest
  • Markets

Astec Lifesciences (ASTEC) Share Price rises 8.08% to Rs 761.85

  • September 8, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Astec Lifesciences Share Price
Astec Lifesciences Ltd. (ASTEC) share price rose to Rs 761.85 today, up 8.08% from the previous close. Market cap was Rs 1,587.99 crore.

Astec Lifesciences Share Price is in focus after the stock traded at Rs 761.85, up 8.08% from the previous close of Rs 704.90, while market capitalisation stood at Rs 1,587.99 crore. The move makes Astec Lifesciences Share Price one of the notable share price gain stories in today’s market update, even though no company-specific catalyst is established. The price move is confirmed in Univest data; a company-specific reason has not been established. That makes the current Astec Lifesciences Share Price move relevant for traders and investors who track price action, valuation, and sector positioning together. In the first hour of trade, the stock already showed a clear gap versus the previous close, and the latest Univest figures place the move among the active Stocks in News within the Chemicals space. Investors watching Astec Lifesciences Share Price today can next monitor whether the move holds near the day’s high and how it compares with the company’s fundamentals. Univest also highlights that today’s event should be read with valuation and peer context, not with any implied cause.

Table of Contents

Toggle
  • Astec Lifesciences Share Price Today: Price Action Analysis
  • Astec Lifesciences Ltd. (ASTEC) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Astec Lifesciences
  • About Astec Lifesciences
  • Frequently Asked Questions
    • Why is Astec Lifesciences Share Price rising today?
    • What is Astec Lifesciences Share Price today?
    • What is Astec Lifesciences Share Price doing in the morning session?
    • How does Astec Lifesciences compare with its industry peers?
    • What does Astec Lifesciences Fundamental Analysis show?
    • Is Astec Lifesciences Share Price expensive versus the sector?
    • Does Astec Lifesciences pay a dividend?
    • Which sector and industry does Astec Lifesciences belong to?
  • Track Astec Lifesciences Share Price on Univest

Astec Lifesciences Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 761.85
Previous Close Rs 704.9
Today's Move Rs 56.95 (+8.08%)
Open Rs 715.25
High Rs 767.3
Low Rs 715.25
Market Capitalisation Rs 1,587.99 crore
Market Cap Category Small Cap

Astec Lifesciences Ltd. (ASTEC) rose to Rs 761.85 from the previous close of Rs 704.9, a move of Rs 56.95 or 8.08%. The stock opened at Rs 715.25, reached a high of Rs 767.3, recorded a low of Rs 715.25.

Astec Lifesciences Share Price today reflects a strong intraday price rise from the previous close, with the stock moving from Rs 704.90 to Rs 761.85 and adding Rs 56.95, or 8.08%. The stock opened at Rs 715.25, touched a high of Rs 767.30 and a low of Rs 715.25, which shows how Astec Lifesciences Share Price has stayed above its opening level through the morning. As of 07 October 2026 at 9:23:04 AM IST, the latest Univest figures show the stock trading near the upper end of the day’s range. For readers tracking Astec Lifesciences Share Price live, this is a clear share price rise within a still-open market session. The move is relevant because the day’s range and the current quote together show the scale of the price change, while the market cap keeps the stock within a Rs 1,587.99 crore valuation bracket. Astec Lifesciences Share Price today now shifts the discussion from raw movement to what the broader fundamentals say.

Astec Lifesciences Ltd. (ASTEC) Fundamental Analysis

Metric Value
Market Capitalisation Rs 1,587.99 crore
P/B Ratio 4.22x
ROE -25.88%
ROCE -5.71%
EPS Rs -29.89
Book Value Per Share Rs 167
Dividend Yield 0%

Astec Lifesciences Ltd. (ASTEC) fundamental metrics show P/B 4.22x, ROE -25.88%, ROCE -5.71%. These ratios show where the company stands today and are not a call to buy or sell.

Astec Lifesciences Ltd. has a market capitalisation of Rs 1,587.99 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/B at 4.22x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -25.88% and ROCE of -5.71%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -29.89, book value per share of Rs 167, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 17.25x, median ROE of 11.01%, median ROCE of 12.96%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric Value
Sector Chemicals
Industry Pesticides & Agrochemicals
Benchmark Scope same industry
Benchmark Median P/E 17.25x
Benchmark Average P/E 30.79x
Benchmark P/E Range 8.7x to 258.58x
Company P/B Ratio 4.22x
Benchmark Median P/B 1.99x
Company ROE -25.88%
Benchmark Median ROE 11.01%
Company ROCE -5.71%
Benchmark Median ROCE 12.96%
Company Market Capitalisation Rs 1,587.99 crore
Benchmark Median Market Cap Rs 899.18 crore

Astec Lifesciences Ltd. (ASTEC) operates in the Chemicals sector, within the Pesticides & Agrochemicals industry.

Astec Lifesciences Ltd. (ASTEC) has a ROE of -25.88%, which is below the benchmark median of 11.01%, a difference of -335.06%. Astec Lifesciences Ltd. (ASTEC) has a ROCE of -5.71%, which is below the benchmark median of 12.96%, a difference of -144.06%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
UPL Ltd. UPL 42,360.42 21.22 1.24 6.95 12
PI Industries Ltd. PIIND 33,579.77 29.3 2.98 12.35 16
Sumitomo Chemical India Ltd. SUMICHEM 20,687.1 36.05 5.8 17.26 23.39
Bayer CropScience Ltd. BAYERCROP 15,775.12 21.7 4.83 23.7 30.08
Sharda Cropchem Ltd. SHARDACROP 6,490.01 10.68 2.07 24.16 31.1

Its ROE of -25.88% compares with a peer median of 17.26% across the companies shown in the table. ROCE stood at -5.71% versus the displayed peer median of 23.39%, providing a capital-efficiency comparison. Astec Lifesciences Ltd. (ASTEC) has a market capitalisation of Rs 1,587.99 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Astec Lifesciences

  • Astec Lifesciences Share Price is up 8.08% today, with the stock trading at Rs 761.85 after a previous close of Rs 704.90.
  • The day’s range, from Rs 715.25 to Rs 767.30, keeps Astec Lifesciences Share Price in active price action territory.
  • Astec Lifesciences Market Cap of Rs 1,587.99 crore gives the move company-size context inside the Chemicals sector.
  • Astec Lifesciences Fundamental Analysis shows P/B at 4.22, EPS at Rs -29.89, ROE at -25.88% and ROCE at -5.71%.
  • In peer comparison, Astec Lifesciences Share Price stands apart because its return ratios trail the named agrochemical peers.

About Astec Lifesciences

Astec Lifesciences Ltd. operates in the Chemicals sector and the Pesticides & Agrochemicals industry. The company’s business context places it in a segment where pricing, product mix and operating execution matter closely for stock performance. Astec Lifesciences Share Price therefore reflects not only market movement, but also how investors compare the business with larger listed names in the same industry. The company is tracked on NSE and BSE, and its market capitalisation is Rs 1,587.99 crore according to latest Univest data. As a listed agrochemicals player, Astec Lifesciences Stock News is typically read through valuation, return ratios and peer comparison, rather than through broad market stories alone. For Univest readers, the company overview is important because it shows where Astec Lifesciences Share Price sits within the industry benchmark and why the stock’s numbers deserve a closer look.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why is Astec Lifesciences Share Price rising today?

Ans. Astec Lifesciences Share Price is rising today because it traded at Rs 761.85, up 8.08% from the previous close. The price move is confirmed in Univest data; a company-specific reason has not been established.

What is Astec Lifesciences Share Price today?

Ans. Astec Lifesciences Share Price today is Rs 761.85. The stock gained Rs 56.95 from the previous close of Rs 704.90, and the market capitalisation stood at Rs 1,587.99 crore.

What is Astec Lifesciences Share Price doing in the morning session?

Ans. Astec Lifesciences Share Price opened at Rs 715.25, touched a high of Rs 767.30 and a low of Rs 715.25. As of 07 October 2026 at 9:23:04 AM IST, it was trading above the open.

How does Astec Lifesciences compare with its industry peers?

Ans. Astec Lifesciences Share Price sits with a market cap of Rs 1,587.99 crore, lower than peers such as UPL, PI Industries and Sumitomo Chemical India. Its ROE and ROCE also trail the named peer set.

What does Astec Lifesciences Fundamental Analysis show?

Ans. Astec Lifesciences Fundamental Analysis shows market cap of Rs 1,587.99 crore, P/B of 4.22, EPS of Rs -29.89, ROE of -25.88%, ROCE of -5.71% and book value of Rs 167.

Is Astec Lifesciences Share Price expensive versus the sector?

Ans. Astec Lifesciences Share Price has a P/B of 4.22, above the industry median of 1.99 and average of 2.33 in the same industry benchmark. That makes book-value comparison an important part of valuation review.

Does Astec Lifesciences pay a dividend?

Ans. Astec Lifesciences shows a dividend yield of 0.00%. That means the current share price move is not being supported by a dividend yield signal, so investors tend to focus more on valuation and return ratios.

Which sector and industry does Astec Lifesciences belong to?

Ans. Astec Lifesciences belongs to the Chemicals sector and the Pesticides & Agrochemicals industry. That placement matters because its share price can be compared directly with sector peers and benchmark multiples.

Track Astec Lifesciences Share Price on Univest

Use Astec Lifesciences Ltd. (ASTEC) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Track Astec Lifesciences Share Price on Univest to follow live price movement, market cap, book value, EPS, ROE, ROCE, and the latest share price update in one place. Univest also brings together the company’s sector context, peer comparison and key valuation ratios so that Astec Lifesciences Share Price Today can be viewed with the right context. If you monitor Astec Lifesciences Stock Analysis regularly, Univest helps keep the share price rise, fundamental analysis and market overview aligned in a single view.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply